Liu Huixin, Qi Jinlei, Yang Jia, Liu Feng, Li Xiaohe, Yin Peng, Wang Lijun, Liang Zhisheng, Wei Lai, Rao Huiying, Zhou Maigeng
Department of Clinical Epidemiology and Biostatistics, Peking University People's Hospital, Beijing, China.
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Diabetes Obes Metab. 2023 Apr;25 Suppl 1:43-52. doi: 10.1111/dom.15010. Epub 2023 Mar 7.
To assess the burden of liver complications related to non-alcoholic fatty liver disease (LC-NAFLD) from 2005 to 2019 in China.
We used data from the Global Burden of Disease, Injuries, and Risk Factors Study, 2019, to present contemporary and varying profiles of China's LC-NAFLD burden. The Joinpoint Regression model and Gaussian process regression were, respectively, used to estimate the annual percentage change in prevalence rates and disability-adjusted life-year (DALY) rates, and the relationship between the sociodemographic index (SDI) and age-standardized rates of LC-NAFLD.
In 2019, China had 293.42 million (95% uncertainty interval [UI]: 263.69-328.44) LC-NAFLD cases with a prevalence rate and DALYs of 20.63 (95% UI: 23.09-18.54) per 1000 people and 591.03 thousand (95% UI: 451.25-737.33), respectively. North China had the highest prevalence but the lowest DALYs of LC-NAFLD, whereas Southwest China had the lowest prevalence but the highest DALYs. LC-NAFLD were more common in men than in women (male: female ratio, 1.27) in 2019. From 2005 to 2019, the prevalence of NAFLD cases increased by 68.32% (from 174.32 million in 2005 to 293.42 million in 2019), mainly because of an age-specific prevalence rate increase.
The LC-NAFLD burden in China is substantial and has increased markedly over the past 15 years. Effective measures for low SDI regions and men are needed to address the rapidly increasing NAFLD burden.
评估2005年至2019年中国非酒精性脂肪性肝病相关肝脏并发症(LC-NAFLD)的负担。
我们使用了《2019年全球疾病、伤害及风险因素负担研究》的数据,以呈现中国LC-NAFLD负担的当代及变化情况。分别使用Joinpoint回归模型和高斯过程回归来估计患病率和伤残调整生命年(DALY)率的年度百分比变化,以及社会人口学指数(SDI)与LC-NAFLD年龄标准化率之间的关系。
2019年,中国有2.9342亿例(95%不确定区间[UI]:2.6369 - 3.2844亿)LC-NAFLD病例,患病率和DALY分别为每1000人20.63例(95% UI:18.54 - 23.09)和59.103万例(95% UI:45.125 - 73.733万)。中国北方LC-NAFLD的患病率最高,但DALY最低,而中国西南地区的患病率最低,但DALY最高。2019年,LC-NAFLD在男性中比女性更常见(男女比例为1.27)。从2005年到2019年,NAFLD病例的患病率增加了68.32%(从2005年的1.7432亿例增加到2019年的2.9342亿例),主要是由于特定年龄患病率的增加。
中国的LC-NAFLD负担很重,在过去15年中显著增加。需要针对低SDI地区和男性采取有效措施,以应对迅速增加的NAFLD负担。